Skip Navigation Bar

History of Medicine Finding Aids

Faye Glenn Abdellah Papers 1952-1989
full text File Size: 103 K bytes | Add this to my bookbag

Box | Folder Title
 
Experiments by Series [subseries]:
 
AE series, 1975
2 22
AE1, 4/3/75
2 23
AE2, 4/4/75
2 24
AE3, 4-9-75 (discarded)
2 25
AE4, 4-10-75
2 26
AE5, 4/14/75
2 27
AE6, 4-17-75
2 28
AE7, 4-28-75
2 29
AE8, 5-7-75
2 30
AE9, 5-8-75
2 31
AE10, 5-19-75
2 32
AE11, 5-20-75 (discarded)
2 33
AE12, 5-22-75
 
AMP series, 1976
2 34
AMP -- behavior, 1976
2 35
D-AMP-DG-1, 6-8-76
2 36
D-AMP-DG-2, 6-16-76
2 37
D-AMP-DG-3, 6-18-76
2 38
D-AMP-4, 8-26-76
2 39
D-AMP-5, 8-26-76
2 40
D-AMP-6, 9-17-76
2 41
D-AMP-7, 12-23-76
2 42
D-AMP-8, 12-23-76
2 43
D-AMP-DG-101, 6-19-76
2 44
D-AMP-102, 6-28-76
2 45
D-AMP-103, 7-3-76
2 46
D-AMP-104, 7-3-76
2 47
D-AMP-105, 7-6-76
2 48
D-AMP-106, 7-7-76
2 49
D-AMP-107, 7-10-76
2 50
D-AMP-108, 7-20-76
2 51
D-AMP-109, 7-20-76
2 52
GU-BR, 1976
3 1
L-AMP-DG-1, 6-12-76
3 2
L-AMP-2, 10-22-76
3 3
L-AMP-3, 12-20-76
3 4
L-AMP-4, 12-21-76
3 5
L-AMP-5, 12-22-76
3 6
L-AMP-6, 12-22-76
3 7
L-AMP-7, 12-23-76
3 8
L-AMP-101, 7-12-76
3 9
L-AMP-102, 7-12-76
3 10
L-AMP-103, 7-15-76
3 11
L-AMP-104, 7-17-76
3 12
L-AMP-105, 7-17-76
 
Antipyrine series, 1969-1976
3 13
Antipyrine [ ]-CBF control 1, 3-29-76
3 14
Antipyrine [ ]-CBF control 2, 4-2-76
3 15
Antipyrine [ ]-CBF control 3, 4-3-76
3 16
Antipyrine c14, [ ]-CBF control 4, 4-5-76
3 17
Antipyrine c14, [ ]-CBF control 5, 4-6-76
3 18
Antipyrine C14, [ ]-CBF control 6, 4-7-76
3 19
Antipyrine partition coefficient in dogs, 1969-1970
3 20
Antipyrine partition coefficient in rats [photograph, negative], 1970
3 21
ARF-8A, LCBF-antip.-1', control, 1975
3 22
Chromatography on antipyrine, n.d.
3 23
Laplace transforms for antip. Sq. wave, 1975-1976
3 24
Series [ ] --IOD: IODO-antip. part. coeff. in rats -- data corrected, 1976
3 25
Series [ ] --IOD; IODO-antip. part. coeff. in rats -- discarded, 1976
3 26
Technical information on IODO-antipyrine, 1976
 
AR series, 1974-1975
3 27
AR-1, P-30' -- 60 uc, experimental, 1974
3 28
AR-1A, P-30' -- 60 uc control, 1974
3 29
AR-2, P-30' -- 60 uc, experimentals, 1974
3 30
AR-3, P-30' -- 60 uc, experimentals, 1974
3 31
AR-3A, P-30' -- 60 uc, control, 1974
3 32
AR-4, P-30' -- 80 uc, experimentals, 1974
3 33
AR-4A, P-30' -- 80 uc, control, 1974
3 34
AR-5, P-30' -- 80 uc, experimentals, 1974
3 35
AR-5A, P-30' -- 80 uc, control, 1974
3 36
AR-6, P-30' -- 80 uc, experimentals, 1974
3 37
AR-6A, P-30' -- 80 uc, control, 1974
3 38
AR-7, P-30' -- 80 uc, experimentals, 1974
3 39
AR-8, P-30' -- 80 uc, experimentals, 1974
3 40
AR-9, anesthesia -- P-30' -- 80 uc, experimentals, 1974
3 41
AR-10, anesthesia -- P-30' -- 80 uc, experimentals, 1974
3 42
AR-11, experimentals, 11-6-75
3 43
AR-12, experimentals, 12-6-75
3 44
AR-13, experimentals, 6-16-75
 
ARF series, 1974-1976
3 45
ARF1 -- LCBF + BARB, 3-20-74
3 46
ARF2 -- LCBF + BARB, 3-20-74
3 47
ARF3 -- LCBF + BARB, 3-21-74
3 48
ARF4 -- LCBF + BARB, 3-21-74
3 49
ARF5, LCBF + BARB, 3-23-74
3 50
ARF-6, 6-16-75
3 51
ARF-7, 6-19-75
3 52
ARF-8, 6-23-75
3 53
ARF-11, 6-21-76
3 54
ARF-12, 6-21-76
3 55
ARF-13, 6-23-76
3 56
ARF-14, 6-23-76
3 57
ARF-15, 6-30-76
3 58
ARF-16, 7-6-76
 
ATP series, 1964-1973
3 59
ATP assay protocol, n.d.
3 60
ATP assays of factor preps., 1966
3 61
Effects of thyroid hormone in vivo on protein biosynthesis -- book 1T, 1964
3 62
Effects of thyroxine in vivo [photographs, negatives], n.d.
3 63
In vivo effect of T4 on microsomal ATP ase (I), 1971
3 64
In vivo effect of T4 on microsomal ATP ase (2), 1972
3 65
In vivo effect of T4/T3 on microsomal ATP ase (3), 1973
3 66
In vivo effect of T4/T3 on microsomal ATPase (4), 1973
4 1
In vivo experiments, n.d.
4 2
Microsomal ATP ase -- prep book, 1970
4 3
Microsomal ATP ase 1, Apr. -- Oct., 1970
4 4
Microsomal ATP ase 2, Oct., 1970, 1970-1972
4 5
Microsomal ATP ase 3, 1971-1972
4 6
Microsomal ATP ase 4, 1972-1973
 
Cat series, 1971-1981
4 7
Cat 1, LCGU 30', 1971
4 8
Cat 3, LCGU 35', 1971
4 9
Anest. Cat 4, 1974
4 10
Cat 101, 10-17-77
4 11
Cat 102, 10-20-77
4 12
Cat 103, 10-27-77
4 13
Cat 104, 11-17-77
4 14
Cat 105, 11-21-77
4 15
Cat 106, 12-1-77
4 16
Cat 107, 12-8-77
4 17
Cat 108, 12-15-77
4 18
Cat 109, 12-21-77
4 19
Cat 110, 12-29-77
4 20
Cat 111, Jan/12/78
4 21
Cat 112, 1-19-78
4 22
Cat 113, 1-26-78
4 23
Cat 114, 2-2-78
4 24
Cat 115, 2-9-78
4 25
Cat 116, 2-23-78
4 26
Cat 117, 3-2-78
4 27
Cat 118, 3-9-78
4 28
Cat 119, 3-14-78
4 29
Cat 120, 3-16-78
4 30
Cat 121, 3-23-78
4 31
Cat 122, 3-24-78
4 32
Cat 123, 3-28-78
4 33
Cat 124, 3-29-98
4 34
Cat awake, rem-4, rem-5, pc-1, 1980
4 35
Cat CBF 2, 1971
4 36
Cat, lumped constant, 1974
4 37
Normal cats, LCBF 1, 1971
4 38
Normal cat CBF 3, 1971
4 39
Normal cat CBF 4, 1971
4 40
Normal cat CBF 5, 1971
4 41
Normal - CFG cat CBF 6, 1971
4 42
SC-1, r. eye patched + 1 PS (P-45' -- 200 uc), 1973
4 43
SC-1A, both eyes patched (P-45 -- 220 uc), 1973
4 44
Series cat: cats -- 30 min. controls, 1980-1981
4 45
Series SQ, Cat 2 - 8 -- lumped constant in cats conscious, 1974-1976
4 46
SLC 1 (control for REM), 1975
4 47
SLC-2, control for REM, 1975
4 48
SLC-3, REM sleep cat, 1975
4 49
SLC-4, REM sleep cat, 1975
4 50
SLC-5, REM sleep cat, 1976
4 51
SQ -- Cat 1, anesth., 1974
4 52
SQ -- Cat 2, anesth., 1974
 
Cerebral Blood Flow (CBF) series, 1953-1993
5 1
1 NMACO2 -- CBF series -- air breathing control, 1990
5 2
2 NMACO2 -- CBF series, air breathing control, 1990
5 3
3 NMACO2 -- CBF series, 5% CO2 in air, 1990
5 4
4 NMACO2 -- CBF series, 5% CO2 in air, 1990
5 5
5 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5 6
6 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5 7
7 NMACO2 -- CBF series, 5% C02 in air, 1990-1991
5 8
8 NMACO2 -- CBF series -- air breathing control, 1990
5 9
9 NMACO2 -- CBF series -- air + N methyl arginine, 1990
5 10
10 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1990
5 11
11 NMACO2 -- CBF series -- air + N methyl arginine, 1990-1991
5 12
12 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5 13
13 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5 14
14 NMACO2 -- CBF series -- 5% CO2 in air, 1990-1991
5 15
15 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5 16
16 NMACO2 -- CBF series -- air breathing control, 1991
5 17
17 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5 18
18 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 19
19 NMACO2 -- CBF series -- air breathing control, 1991
5 20
20 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5 21
21 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 22
22 NMACO2 -- CBF series -- air + N methyl arginine, 1991
5 23
23 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5 24
24 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 25
25 NMACO2 -- CBF series -- air breathing control, 1991
5 26
26 NMACO2 -- CBFG series -- air + N methyl arginine, 1991
5 27
27 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 28
28 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 29
29 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5 30
30 NMACO2 -- CBF series - - 5% CO2 + N methyl arginine (30 mg/kg), 1991
5 31
31 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 32
32 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 33
33 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 34
34 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5 35
35 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (30 mg/kg), 1991
5 36
36 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 37
37 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 38
38 NMACO2 -- CBF series -- air + N methyl arginine (30 mg/kg), 1991
5 39
39 NMACO2 -- CBF series -- air + saline, 1991
5 40
40 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine (100 mg/kg), 1991
5 41
41 NMACO2 -- CBF series -- 5% CO2 + N methyl arginine, 1991
5 42
42 NMACO2 -- CBF series -- air + N methyl arginine (100 mg/kg), 1991
5 43
43 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 44
44 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 45
45 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 46
46 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 47
47 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 48
48 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 49
49 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 50
50 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 51
51 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 52
52 NMACO2 -- CBF series -- 5% CO2 + NMA (100 mg/kg), 1991
5 53
53 NMACO2 -- CBF series -- air + NMA (100 mg/kg), 1991
5 54
54 NMACO2 -- CBF series -- air + saline, 1991
5 55
55 NMACO2 -- CBF series -- air + saline (eliminated), 1991
5 56
56 NMACO2 -- CBF series -- air + saline, 1991
5 57
57 NMACO2 -- CBF series -- air breathing control, 1991
5 58
58 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5 59
59 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5 60
60 NMACO2 -- CBF series -- air breathing control, 1991
5 61
61 NMACO2 -- CBF series -- air breathing control, 1991
5 62
62 NMACO2 -- CBF series -- 5% CO2 in air, 1991
5 63
63 NMACO2 -- CBF series -- saline + 5% CO2, 1991
5 64
64 NMACO2 -- CBF series -- saline + air, 1991
5 65
65 NMACO2 -- CBF series -- saline + air, 1991
5 66
66 NMACO2 -- CBF series -- saline + 5%CO2, 1991
5 67
67 NMACO2 -- CBF series -- air + NMA (30 mg/kg), 1991
5 68
68 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5 69
69 NMACO2 -- CBF series --5% CO2 + NMA (10 mg/kg), 1991
5 70
70 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5 71
71 NMACO2 -- CBF series -- 5% CO2 + NMA (10 mg/kg), 1991
5 72
72 NMACO2 -- CBF series -- air + NMA (10 mg/kg), 1991
5 73
NMA-73, NMA 10 mg/kg + air, 1992
5 74
NMA-74, NMA 10 mg/kg I.V + air, 1992
5 75
NMA-75, NMA 30 mg/kg I.V. + air, 1992
5 76
NMA-76, NMA 10 mg/kg I.V. + 5% CO2, 1992
5 77
77 NTRO-1, CO2 and saline I.V., 1992
5 78
78 NTRO-2, CO2 and nitro, 1992
5 79
79 NTRO-3, air and nitro 30 mg/kg i.v., 1992
5 80
80 NTRO-4, air and nitro, 1992
5 81
81 NTRO-5, CO2 and nitro, 1992
5 82
82 NTRO-6, CO2 and saline i.v., 1992
5 83
83 NTRO-7, CO2 and saline i.v., 1992
6 1
84 NTRO-8, CO2 and nitro, 1992
6 2
85 NTRO-9, air and nitro, 1992
6 3
86 NTRO-10, CO2 and nitro 30 mg/kg i.v., 1992
6 4
87 NTRO-11, air + nitro 30 mg/kg i.v., 1992
6 5
88 NTRO-12, CO2 and nitro 30 mg/kg i.v., 1992
6 6
89 NTRO-13, air and nitro, 1992
6 7
90 NTRO-14, air and nitro, 1992
6 8
91 NTRO-15, CO2 and nitro, 1992
6 9
92 NTRO-16, CO2 and nitro, 1992
6 10
93 NTRO-17, 5% CO2 and nitro 30 mg/kg, 1992
6 11
95 NTRO-19, 5% CO2 and nitro 30 mg/kg i.v., 1992
6 12
96 NTRO-20, nitro-topical, 1992
6 13
97 NTRO-21, nitro-topical, 1992
6 14
98 NTRO-22, nitro-topical, 1992
6 15
98 NTRO-23, nitro-topical, 1992
6 16
100 NTRO-24s, air and nitro 30 mg/kg, 1993
6 17
101 NTRO-25s, air + nitro 30 mg/kg, 1993
6 18
102 NTRO-26s, 5% CO2 and nitro 30 mg/kg i.v., 1993
6 19
103 NTRO-27s, nitro 30 mg/g i.v. and 5% CO2, 1993
6 20
104 (28), CO2 and NTRO, 1993
6 21
105 (29), CO2 and NTRO, 1993
6 22
106 (30), air and NTRO, 1993
6 23
107 (31), air and NTRO, 1993
6 24
NTRO 108, chronic i.p. and CO2, 1993
6 25
NTRO 109, chronic i.p. and CO2, 1993
6 26
NTRO 110, chronic i.p. and air, 1993
6 27
NTRO 111, chronic i.p. and air, 1993
6 28
NTRO 112, chronic i.p. and air, 1993
6 29
NTRO 113, chronic i.p. and CO2, 1993
6 30
NTRO 114, chronic i.p. and CO2, 1993
6 31
NTRO 115, chronic i.p. and CO2, 1993
6 32
NTRO 116, chronic i.p. and air, 1993
6 33
NTRO 117, chronic i.p. and air, 1993
6 34
NTRO 118, chronic i.p. and air, 1993
6 35
NTRO 119, chronic i.p. and CO2, 1993
6 36
NTRO 120, saline chronic i.p. and CO2, 1993
6 37
NTRO 121, saline chronic i.p. and CO2, 1993
6 38
NTRO 122, saline chronic i.p. and air, 1993
6 39
NTRO 123, saline chronic i.p. and air, 1993
6 40
NTRO 124, saline chronic i.p. and air, 1993
6 41
NTRO 125, saline chronic i.p. and CO2, 1993
6 42
NTRO 126, 1993
6 43
NTRO 127, 1993
6 44
NTRO 128, 1993
6 45
NTRO 129, 1993
6 46
NTRO 130, 1993
6 47
NTRO 131, saline chronic i.p. and CO2, 1993
6 48
NTRO 132, saline chronic i.p. and CO2, 1993
6 49
NTRO 133, saline chronic i.p. and CO2, 1993
6 50
14c-NMA distribution, 1993
6 51
Brain tissue NMA assay, 1992
6 52
Calculations for CBF (Kety-Schmidt), n.d.
6 53
CBF -- ischemia experiments, 1980
6 54
CBF -- LSD -- normals, 1954-1955
6 55
CBF -- n.20 -- normal young, 1957-1958
6 56
CBF -- nitrous oxide - Pitressin, 1956
6 57
CBF -- nitrous oxide -- children [photographs], 1957
6 58
CBF -- thyroid disease, n.d.
6 59
CBF aged -- continued, 1956-1957
6 60
CBF exp., n.d.
6 61
CBF lysergic acid [photographs], 1955
6 62
Cerebral blood flow, 1957-1958
6 63
Cerebral blood flow -- book II, 1954-1957
6 64
Cerebral blood flow 3, 1955
6 65
Changes in CBF during REM sleep (fig. 3) (from Reivitch, et. al.) [slides], 1977
6 66
Chemical assay in NMA study, 1992
6 67
CO2 study -- local CBF, n.d.
6 68
CBF -- LSD -- schizophrenia, 1954-1955
6 69
KR 79 CBF studies [photographs], 1953-1955
6 70
Local C.B.F III, 1954-1955
6 71
Local C.B.F. II, 1953-1954
6 72
Local C.B.V IV, 1955-1957
6 73
NMA Co2 series, n.d.
6 74
NMA2DG series: animal 01 control, 1991
6 75
NMA2DG series: animal 02, exp. NMA 3 mg., 1991
6 76
NMA2DG series: animal 3, exp. NMA 3 mg/kg, 1991
6 77
NMA2DG series: animal 4 control, 1991
6 78
NMA2DG series: animal 05, exp. NMA 3mg/kg, 1991
6 79
NMA2DG series: animal 06 control, 1991
6 80
NMA2DG series: animal 07, exp. NMA 3mg/kg, 1991
6 81
NMA2DG series: animal 08 control, 1991
6 82
NMA2DG series: animal 09 control, 1991
6 83
NMA2DG series: animal 10 control (eliminated), 1991
7 1
NMA2DG series: animal 11 control, 1991
7 2
NMA2DG series: animal 12 control, 1991
7 3
NMA2DG series: animal 13 control, 1991
7 4
NMA2DG series: animal 14, exp. NMA 100 mg/kg, 1991
7 5
NMA2DG series: animal 15, exp. NMA 100 mg/kg, 1991
7 6
NMA2DG series: animal 16 control, 1991
7 7
NMA2DG series: animal 17, exp. NMA 100 mg/kg, 1991
7 8
NMA2DG series: animal 18 control, 1991
7 9
NMA2DG series: animal 19, exp. NMA 100 mg/kg, 1991
7 10
NMA2DG series: animal 20, exp. NMA 100 mg/kg, 1991
7 11
NMA2DG series: animal 21, exp. NMA 100 mg/kg, 1991
7 12
NMACO2 summaries, 1992
7 13
NMA-DG, data sheet, 1991-1992
7 14
Regional cerebral blood flow (Tbl 2) (from Reivitch, et. al.), 1977
 
CI* series
7 15
Ci *(t)/Cp*(t) vs. stretch time <pulse experiments>, 1979
7 16
Ci ct/Cp* vs. real time or stretch time -- weighted average, 1979-1985
7 17
Ci*(t)/Cp*(t) vs. stretch time (pulse experiments), n.d.
7 18
Local tissue 14c concentration (gray) Ci*Ct/Cp* (gray) [folder 1 of 2], 1979-1986
7 19
Local tissue 14c concentration (gray) Ci*Ct/Cp* (gray) [folder 2 of 2], 1979-1986
7 20
Local tissue 14c concentration (white) -- Ci ct/Cp* (white), 1975-1985
7 21
Lt Cp*dt -- pulse exp., 1979
7 22
Pulse (mori) -- local Ci* - ci*/Cp*, 1979-1984
7 23
Square wave experiments -- Ci*(t)/Cp*(t) vs. stretch time -- vs. real time Ci*(t)/Cp*, n.d.
7 24
Weighted average -- Ci*(t)/Cp*(t) vs. stretch time -- pulse experiments, 1979
 
CR series, 1972-1976
7 25
CB-4, B-20 uc -- 45', CO2 -- 86', 1975
7 26
CB-5, B-20 uc -- 45', CO2 -- 86', 1975
7 27
CB-6, Pul. -- 20 uc -- 45', CO2 -- 90', 1975
7 28
CB-7, LCGU-45' -- 30 uc, CO2 -- 75', 1975
7 29
CB-8, discarded, 1975
7 30
CB-9, LCGU -- 45' -- 30 uc, CO2 -- 75', 1975
7 31
Series CRO: 5% CO2, 45' exposure, n.d.
7 32
CR-1, LCGU + CO2, P-30' 80 uc, 1974
7 33
CR-2, LCGU + CO2, P-30' -- 80 uc, 1974
7 34
CR-3, LCGU + CO2, P-30' -- 80 uc, 1974
7 35
CR-4, LCGU + CO2, P-33' -- 90 uc, 1974
7 36
CR-5, LCGU + CO2, P-30' -- 90 uc, 1974
7 37
CR-101, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7 38
CR-102, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7 39
CR-103, LCGU -- 30' -- 75 uci, CO2 -- 45', 1975
7 40
CR-104, LCGU -- 30' -- 50 uci, CO2 -- 45', 1975
7 41
CR-105, LCGU -- 30' -- 70 uci, CO2 -- 45', 1975
7 42
CRF-1, 85 uc, LCBF + CO2-74 min., 1974
7 43
CRF-2, 85 uc, LCBF + CO2 -- 70', 1974
7 44
CRF-3, 85 uc, LCBF + CO2 -- 45', 1974
7 45
CRF-4, 68 uc, LCBF + CO2 -- 48', 1974
7 46
CRF-5, 68 uc, LCBF + CO2 -- 45', 1974
7 47
CRF-6, 85 uc, LCBF + CO2 -- 41', 1974
7 48
CRF-7, 85 uc, LCBF + CO2 -- 26', 1974
7 49
CRF-8, 85 uc, LCBF + CO2 -- 38', 1974
7 50
CRF-9, 85 uc, LCBF + CO2 -- 43', 1974
7 51
CRF-10, 85 uc, LCBF + CO2 -- 42', 1974
7 52
CRF-11, 85 uc, LCBF + CO2 -- 11', 1975
7 53
CRF-12, 85 uc, LCBF + CO2 -- 12', 1975
7 54
CRF-13, 85 uc, LCBF + CO2 -- 12', 1975
7 55
CRF-14, 85 uc, LCBF + CO2 -- 16', 1975
7 56
CRF-15, 68 uc, LCBF + CO2 -- 14', 1975
7 57
CRF-101, LCBF -- 1', 10% CO2 -- 45', 1975
7 58
CRF-102, LCBF -- 1', 10% CO2 -- 45', 1975
7 59
CRF-103, LCBF -- 1', 10% CO2 -- 45', 1975
7 60
CRF-104, LCBF -- 1', 10% CO2 -- 45', 1975
7 61
CRF-105, LCBF (Ant. 1'), 10% CO2 -- 45', 1975
7 62
Series CRF 111-115 : 10% CO2 + 10' exposure, 1975
7 63
CRF-201, 20% CO2, 1976
7 64
L.C.B.F. : effects of CO2 in puppy, 1972
 
DEX series, 1979
8 1
Dex-1, 1-30-79
8 2
Dex-2, 3-12-79
8 3
Dex-3, 3-14-79
8 4
Dex-4, 3-16-79
8 5
DEx-5, 4-19-79
8 6
Dex-Px-1 (21 mg/kg), 1-15-79
8 7
Dex-Px-2 (21 mg/kg), 3-12-79
8 8
Dex-Px-3 (21 mg/kg/min.), 3-14-79
8 9
Dex-Px-4 (21 mg/kg), 3-16-79
8 10
Dex-Px-5 (21 mg/kg), 3-21-79
 
Deoxyglucose (DG) series, 1973-1979
8 11
% of free DG in grey and white matter, 1977
8 12
DG-1, 30' -- B, 1973
8 13
DG-2 (C14), 1973
8 14
DG-3, 45' cont., 1973
8 15
DG-101, 30' -- B, 1973
8 16
DG-102, B -- 30' -- 51 uc, 1973
8 17
DG-103, B-45'-76 uc, 1973
8 18
DG-104, B-45' -- 76 uc, 1973
8 19
DG-105 B-120' (51 uc x 1 ½'), 1973
8 20
DG-106, B-45' -- 51 uc, 1973
8 21
DG-107 B-120" (51 uc x 1 ½'), 1973
8 22
DG-108, B-45' -- 51 uc, 1973
8 23
DG-111, B-75' -- 51 uc, 1973
8 24
DG-112, B-75 -- 51 uc, 1973
8 25
DG-113, B-90' -- 51 uc, 1973
8 26
DG-114, B-90' -- 51 uc, 1973
8 27
DG-115, LCGU -- control 45', 1975
8 28
DG-116, LCGU -- control 45' (30 uc), 1975
8 29
DG-117, LCGU -- 30' -- 50 uc, 1975
8 30
DG-118, LCGU -- 30', control, 1975
8 31
DG-119, LCGU -- 30' -- 50 uc, control, 1975
8 32
DG-120, LCGU -- 30' -- 50 uc, control, 1975
8 33
DG-121, normal control 45', 1976
8 34
DG-125, LCGU normal control rat, 30', 1976
8 35
DG-126, LCGU -- normal control rat 45', 1976
8 36
DG-127, LCGU -- normal control, 45', 1976
8 37
DG-128, LCGU -- normal control rat, 45', 1976
8 38
DG-129, LCGU -- normal control rat, 45', 1976
8 39
DG-130, LCGU -- normal control, 30', 1976
8 40
DG-131, LCGU -- normal control, 30', 1976
8 41
DG-132, LCGU normal control, 30', 1976
8 42
DG-133, LCGU -- normal control, 30', 1976
8 43
DG-134, LCGU -- normal control rat, 45' (discarded), 1976
8 44
DG-135, LCGU -- light flow rate of anesthetic gas mixture, 45', 1976
8 45
DG-137, LCGU -- tight mask + high flow rate of anesthetic gas mixture, 30', 1976
8 46
DG-138, normal control rat, 45', 1976
8 47
DG-141, high flow rate of gas mix with tight mask, 30', 1976
8 48
DG-142, low flow rate of gas mix with loose mask, 30', 1976
8 49
DG-143, normal control rat, 45', 1976
8 50
DG-144, normal control rat, 45', 1976
8 51
DG-145, normal control rat, 45', 1976
8 52
DG-146, normal control rat, 45', 1976
8 53
DG-147, normal control rat, 45' (discarded), 1976
8 54
DG-170, 8-16-77
8 55
DG-182, 45 min. (C.K.) 7-27-78
8 56
DG-183, 30 min. (C.K.) 7-27-78
8 57
DG-184, 7-27-78, 20 min. C.K.
8 58
DG-185, 45 m in. (C.K.) 7-31-78
8 59
DG-186, 30 min. (C.K.) 7-31-78
8 60
DG-190, 45 min. (C.K.) 9-11-78
8 61
DG-191, 9-11-78, 20' control
8 62
DG-192, 60 min. (C.K.) 9-14-78
8 63
DG-193, 45 min. (C.K.) 9-18-78
8 64
DG-194, 90 min. (C.K.) 9-21-78
8 65
DG-195, 9-21-78, 20 min. C.K.
8 66
DG-196, 10-2-78, 20 min. C.K.
8 67
DG-198, 30 min. (C.K.) 10-5-78
8 68
DG-199, 10-16-78, 20 min. C.K.
9 1
DG-200, 30 min (C.K.) 10-16-78
9 2
DG-201, 45 min. (C.K.) 10-19-78
9 3
DG-201, 5' -- C -- 51 uc, 1973
9 4
DG-202, 60 min (C.K.) 10-19-78
9 5
DG-202., 5' -- C -- 51 uc, 1973
9 6
DG-203, 10' -- C 39 uc, 1973
9 7
DG-203, 90 min. 10-23-78
9 8
DG-204, 10' -- C 39 uc, 1973
9 9
DG-204, 60 min. 10-23-78
9 10
DG-205, 10' -- C -- 39 uc, 1973
9 11
DG-205, 60 min. control, 1978
9 12
DG-206, 5' -- C 51 uc, 1973
9 13
DG-207, 10' -- C -- 39 uc, 1973
9 14
DG-207, 60 min. 12-22-78
9 15
DG-208, 20' -- C -- 34 uc, 1973
9 16
DG-209, 20' -- C -- 34 uc, 1973
9 17
DG-209, 45 min. (C.K.) 12-28-78
9 18
DG-210, 20' -- C -- 34 uc, 1973
9 19
DG-210, 30 min 12-28-78
9 20
DG-211, 1-4-79, 20 min. control
9 21
DG-211, C -- 30' -- 29 uc, 1973
9 22
DG-212, 30' -- C -- 29 uc, 1973
9 23
DG-212, 90 min. 1-11-79
9 24
DG-213, 90 min. 1-15-79
9 25
DG-213, C -- 30' -- 29 uc, 1973
9 26
DG-214, 90 min. 1-18-79
9 27
DG-214, C -- 45' -- 23 uc, 1973
9 28
DG-215, 90 min. 1-18-79
9 29
DG-215, C -- 45' -- 23 uc, 1973
9 30
DG-216, C -- 1' -- 68 uc, 1973
9 31
DGX-1, BoP. -- 6 hrs., 1973
9 32
DGX-2, BoP. -- 17 hrs., 1973
9 33
DGX-3, BoP -- 24 hrs., 1973
9 34
Summary of DGX-1, DGX-2, DGX-3 data, 1973
 
DL series, 1971-1973
9 35
DL-X, 1972
9 36
Series DL1 -- DL11 : 20 mg/kg, experimentals, 1971
9 37
Series DL 1A -- DL 11A : 20 mg/kg controls, 1972
9 38
Series DL101 -- DL110 : 100 mg/kg, experimentals, 1971
9 39
Series DL201-DL206 : 50 mg/kg, experimental, 1972
9 40
Series DL207A -- DL215A : 50 mg/kg, controls, 1972
9 41
Series DL208 -- DL211 : 50 mg/kg, experimentals, 1972
9 42
Series DL213 -- DL214 : 50 mg/kg, experimentals, 1975
9 43
Series DL301 and DL302 : 50 mg/kg, experimental, 1972
9 44
Series DL301A -- DL303A : 50 mg/kg, controls, 1972
9 45
Series DL304 -- DL307 : 50 mg/kg, experimentals, 1972
9 46
Series DL306A -- DL309A : 50 mg/kg, controls, 1972-1973
9 47
Series DL-309 : 50 mg/kg, experimentals, 1973
 
E/E series, 1974-1975
9 48
E/E 1and2, discarded, 1974
9 49
E/E 3, 1974
9 50
E/E 4, 1974
9 51
E/E 5, 1974
9 52
E/E 6, 1974
9 53
Rat E/E 7, 1974
9 54
E/E 8, 11-7-74
9 55
E/E 9, 11-14-74
9 56
E/E 10, 12-12-74
9 57
E/E 11, 1974
9 58
E/E 12, 1974
9 59
E/E 13, Jan. 10, 1975
9 60
E/E 14, 1-13-75
9 61
E/E 15, 1-17-75
9 62
E/E 16, 1-23-75
9 63
E/E 17, 1-27-75
9 64
E/E 18, 2-6-75
9 65
E/E 19, 2-10-75
9 66
E/E 20, 2-13-75
9 67
E/E 21, Feb. 14, '75
9 68
E/E 26, and 27, cancelled, 1975
9 69
E/E 29 discarded, 1975
 
G6 series, 1985, 1987
9 70
G6 pase 1, 1985
9 71
G6 pase 2, 1985
9 72
G6 pase 3, 1985
9 73
G6 pase 4, 1985
9 74
G6 pase 5, 1985
9 75
G6 pase 6, 1985
9 76
GA pase 7, 1985
9 77
G6 pase 8, 1985
9 78
G6 pase 9, 1985
9 79
G6 pase 10, 1985
9 80
G6 pase 11, 1985
9 81
G6 pase 12, 1985
9 82
G6 pase 13 -- Aug. 2, 85
9 83
G6 pase 14, 1985
9 84
G6 pase 15, 1985
9 85
G6 pase 16, 1985
9 86
G6 0ase 17 -- Aug. 5, 85
9 87
G6 pase 18 -- Aug. 5, 85
9 88
G6 pase 19 -- Aug.; 5, 85
9 89
G6 pase 20 -- Aug. 5, 85
9 90
G6 pase 21 -- Aug. 1, 85
9 91
G6 pase 22 -- Aug. 6, 85
9 92
G6 pase 23 -- Aug. 6, 85
9 93
G6 pase 24 -- Aug. 6, 85
9 94
G6 pase 25 -- Aug. 7, 85
9 95
G6 pase 26 -- Aug. 7, 85
9 96
G6 pase 27 -- Aug. 7, 85
9 97
G6 pase 28 -- Aug, 7, 85
9 98
G6 pase 29 -- Aug. 8, 85
10 1
G6 pase 30 -- Aug. 8, 85
10 2
G6 pase 31 -- Aug. 8, 85
10 3
G6 pase 32 -- Aug. 8, 85
10 4
G6 pase 33 -- Aug. 9, 85
10 5
G6 pase 34 -- Aug. 9, 85
10 6
G6 pase 35 -- Aug. 9, 85
10 7
G6 pase 36 -- Aug. 9, 85
10 8
G6 pase 37 -- Aug. 10, 85
10 9
G6 pase 38 -- Aug. 10, 85
10 10
G6 pase 39, 1985
10 11
G6 pase 40, 1985
10 12
G6 pase 41, 1985
10 13
G6 pase 42 -- 60 min. -- Aug. 13, 1985
10 14
G6 pase 43, 1985
10 15
G6 pase 44 -- Aug. 14, 85
10 16
G6 pase 45 -- 90 min. -- Aug. 14, 85
10 17
G6 pase 46 -- 2.5 min. -- Aug. 14, 85
10 18
G6 pase 47 -- 15 min. -- Aug. 14, 85
10 19
G6 pase 48 -- 60 min. Aug. 16, 85
10 20
G6 pase 49 -- 30 min. -- Aug. 16, 85
10 21
G6 pase 50 -- 15 min. -- Aug. 16, 85
10 22
G6 pase 51 -- Aug. 17, 85
10 23
G6 pase 52 -- Oct. 16, 85
10 24
G6 pase 53 -- Oct. 16, 85
10 25
G6 pase 54 -- Nov. 27, 85
10 26
G6 pase 55 -- Nov. 27, 85
10 27
G6 pase 56 -- Nov. 29, 85
10 28
G6 pase 57 -- Nov. 29, 85
10 29
G6 pase 58 -- Nov. 29, 85
10 30
G6 pase P1 -- Aug. 15, 85
10 31
G6 pase P2 -- Aug. 15, 85
10 32
G6 pase P3 -- Aug. 16, 85
10 33
G6 pase P4 -- Aug. 16, 85
10 34
G6 pase P5 -- Aug. 16, 85
10 35
G6 pase P6 -- Aug. 27, 85
10 36
G6 pase P7 -- Aug. 85
10 37
G6 pase, 1985
10 38
G6 pase -- vol. I -- no. 1 -- no. 13, 1985
10 39
G6 pase -- vol. II -- no. 14 -- no. 25, 1985
10 40
G6 pase -- vol. III -- no. 26 -- no. 37, 1985
10 41
G6 pase -- vol. IV -- no. 38 -- no. 49, 1985
10 42
G6 pase -- P -- vol V, 1985
10 43
G6 pase -- vol. VI -- no. 50, 1985
10 44
G6 pase (square) -- anova, 1987
10 45
Physiological conditions -- G6 pase 1~58, n.d.
 
HLNC series, 1976
10 46
Helen and Larry normal control series, n.d.
10 47
HLNC-DG-1, 6-25-76
10 48
HLNC-DG-2, 6-25-76, discarded
10 49
HLNC-3, 6-28-76
10 50
HLNC-4, 7-1-76
10 51
HLNC-5, 7-2-76
10 52
HLNC-6, 7-6-76
10 53
HLNC-7, 7-10-76
10 54
HLNC-8, 8-24-76
10 55
HLNC-9, 8-24-76
10 56
HLNC-10, 10-22-76
10 57
HLNC-11, 12-18-76
10 58
HLNC-12, 12-18-76
10 59
HLNC-13, 12-20-76
10 60
HLNC-14, 12-21-76
10 61
HLNC-15, 12-22-76
 
HIG series, 1977-1978
10 62
HIG-1, 11-28-77
10 63
HIG-2, 11-28-77
10 64
HIG-3, 12-2-77
10 65
HIG-4, 5-11-78
10 66
HIG-5, 5-31-78
10 67
HIG-NS-1, 1-11-78
10 68
HIG-saline-2, 2-7-78
10 69
HIG-saline-9, 7-12-78
11 1
Nacl-01, 6-22-78
11 2
Nacl-03, 7-10-78
11 3
Nacl-04, 7-11-78
11 4
Nacl-05, 7-12-78
11 5
Nacl-3, 2-13-78
11 6
Nacl-4, 2-22-78
11 7
Nacl-5, 4-4-78
11 8
Nacl-6, 4-18-78
11 9
Nacl-7, 5-3-78
11 10
Nacl-8, 5-10-78
 
Hyperglycemia (LC) series, 1980-1987
11 11
LC -- hyperglycemia 1, 15 Jan. '80
11 12
LC -- hyperglycemia 2, 28 Jan '80
11 13
LC -- hyperglycemia 3, Feb. 1 '80
11 14
LC -- hyperglycemia 4, 2/3/80
11 15
LC -- hyperglycemia 5, 2/6/80 -- Franz, Francesco, Jane, Esther, Sumio
11 16
LC -- hyperglycemia 6, 2/20/80
11 17
LC -- hyperglycemia 7, 3/3/80 -- Franz, Francesco, Jane, Esther, Sumio
11 18
LC -- hyperglycemia 8, 3/12/80 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane Jehle, Esther
11 19
LC -- hyperglyc. 9, 3/18/80 -- Franz, Francesco, Sumio, Jane, Dr. Kennedy, Wolfgang, Esther
11 20
LC -- hyperglycemia 10, 3/27/80 -- Franz, Francesco, Sumio, Esther, Wolfgang, Dr. Kennedy
11 21
LC -- hyperglycemia 11, 3/31/80 -- Franz, Francesco, Sumio, Dr. Kennedy, Wolfgang, Jane
11 22
LC -- hyperglycemia 12, 4/22/80 -- Franz, Francesco, Sumio, Jane Jehle, Esther
11 23
LC -- hyperglycemia 13, 4/29/80 -- Franz, Francesco, Sumio, Jane, Esther
11 24
LC -- hyperglycemia 14, 5/6/80 -- Franz, Francesco, Sumio, Jane, Esther
11 25
LC -- hyperglycemia 15, 5/8/80 -- Franz, Francesco, Sumio, Jane, Esther
11 26
LC -- hyperglycemia 16, 5/13/80 -- Franz, Francesco, Jane, Esther
11 27
LC -- hyperglycemia 17, 5/19/80 -- Franz, Francesco, Sumio, Jane, Esther
11 28
LC -- hyperglycemia 18, 5/21/80 -- Franz, Francesco, Sumio, Jane
11 29
LC -- hyperglycemia 19, 5/23/80 -- Franz, Francesco, Sumio, Jane, Esther
11 30
LC -- hyperglycemia 20, 5/30/80 -- Franz, Francesco, Jane, Sumio, Esther
11 31
LC -- hyperglycemia 21, 5/30/80 -- Franz, Francesco, Jane, Sumio
11 32
LC -- hyperglycemia 22, 6/9/80 -- Franz, Francesco, Jane
11 33
LC -- hyperglycemia 23, 6/11/80 -- Franz, Francesco, Jane
11 34
LC -- hyperglycemia 24, 6/16/80 -- Franz, Francesco, Jane
11 35
LC -- hyperglycemia 25, 6/19/80 -- Franz, Francesco, Jane
11 36
LC -- hyperglycemia 26, 6/25/80 -- Franz, Francesco, Jane
11 37
LC -- hyperglycemia 27, 7/1/80 -- Franz, Francesco, Jane, Esther
11 38
LC -- hyperglycemia 28, 7/8/80 -- Franz, Francesco, Sumio, Jane, Esther
11 39
LC -- hyperglycemia 29, 7/10/80 -- Franz, Francesco, Jane, Esther
11 40
LC -- hyperglycemia 30, 7/17/80 -- Franz, Francesco, Jane, Esther
11 41
LC -- hyperglycemia 31, 7/21/80 -- Franz, Francesco, Jane, Esther
11 42
LC -- hyperglycemia 32, 7/24/80 -- Franz, Francesco, Jane, Sumio, Esther
11 43
LC- hyperglycemia -- compiled data, 1980-1987
11 44
LC -- hyperglycemia -- error analyses, counting procedures, etc., 1980
11 45
LC table -- species, n.d.
 
Iodoantipyrine (IOD) series, 1976-1977
11 46
Iodoantipyrine [ ]-CBF control 1, 4-1-76
11 47
Iodoantipyrine [ ]-CBF control 2, 4-2-76
11 48
Iodoantipyrine [ ]-CBF control 3, 4-3-76
11 49
14c -- iodoantiyprine, [ ]-CBF control 4, 4-6-76
11 50
14c -- iodoantipyrine, [ ]-CBF control 5, 4-6-76
11 51
14c -- iodoantipyrine -- [ ]-CBF control 6, 4-7-76
11 52
Chromatography for 14c -- iodoantipyrine -- 7-7-76
11 53
Chromatography of iodoantipyrin experiment -- by J. D. Brown, 1976
11 54
Dissolve of 14c -- iodoantipyrine into dioxane phosphov., n.d.
11 55
IOD-C-7, 14c iodoantiyprine normal cat -- 8-19-76
11 56
IOD-C-8, 1-6-77
11 57
Iodoantipyrine cat normal control 1, 5-6-76
11 58
Iodoantipyrine cat normal control 2, 5-14-76
11 59
Iodoantipyrine normal CBF cat 3, 5-20-76
11 60
Iodoantipyrine normal control 4, 5-27-76
11 61
Iodoantipyrine cat normal control 5, 6-4-76
11 62
Iodoantipyrine cat normal control 6, 6-11-76
11 63
Iodoantipyrine cat study summary, n.d.
11 64
Iodoantipyrine solubility property, n.d.
11 65
Iodoantipyrine study summary, n.d.
11 66
Iodoantipyrine, radiochromatogram - CFG 1265, 1976
11 67
Iodoantipyrine, radiochromatogram -- CFQ 1460, 1976
 
IP series, 1993
11 68
IPBF 1-4, 1993
11 69
IPBF 5-8, 1993
11 70
IPBF 9-12, 1993
11 71
IPBF 13-16, 1993
11 72
IPBF 17-20, 1993
12 1
IPBF 21-24, 1993
12 2
IPBF 25-28, 1994
12 3
IPBF 29-32, 1994
12 4
IPDG 2 L-NAME, 1993
12 5
IPDG 3 L-NAME, 1993
12 6
IPDG 4 saline, 1993
12 7
IPDG 5, saline, 1993
12 8
IPDG 6, L-NAME, 1993
12 9
IPDG 7, L-NAME, 1993
12 10
IPDG 8, saline, 1993
12 11
IPDG 9, saline, 1993
12 12
IPDG 10, L-NAME, 1993
12 13
IPDG 11, saline, 1993
12 14
IPDG 12, saline, 1993
12 15
IPDG 13, L-NAME, 1993
12 16
IPDG 14, saline, 1993
12 17
IPDG 15, saline, 1993
12 18
IPDG 16, L-NAME, 1993
12 19
IPDG 17, saline, 1993
12 20
IPDG 18, saline, 1993
 
KSA series, 1975-1976
12 21
Antipyrine chromatography, KSA 101 and 102 (plasma), 1975
12 22
Series KSA-0: antipyrine for BDBF pulse inf. for laplace transf., n.d.
12 23
KSA-101, CBF (K-s) antipyrine, sq. wave 60', 1975
12 24
KSA-102, CBF (K-S) antipyrine, sq. wave 35', 1975
12 25
KSA-103, CBF (K-S) antipyrine, pulse-50 uc-60', 1975
12 26
KSA-103: chromatography on plasma and brain, 1976
12 27
KSA-104 and 105, in brain and plasma, 1976
12 28
KSA-104, discarded, 1976
12 29
KSA-105, discarded, 1976
12 30
KSA-106, discarded, 1976
12 31
KSA-107, discarded, 1976
12 32
KSA-108, discarded, n.d.
12 33
KSA-109, discarded, 1976
12 34
KSA-110, discarded, 1976
12 35
KSA-114, discarded, 1976
12 35
KSA-118, discarded, 1976
12 37
KSA-119, discarded, 1976
12 38
KSA-120, discarded, 1976
12 39
KSA-124, n.d.
12 40
KSA-127, discarded, 1976
12 41
KSA-128, discarded, 1977
12 42
KSA-129, normal control (immobilization), 1977
12 43
KSA-131, 5% CO2, CBF, 1977
12 44
KSA-132, normal control, 1977
12 45
KSM-101, methylglucose as tracer for GCBF, 1975
12 46
KSM-102, methylglucose as tracer for GCBF, 1975
12 47
Series KSH: hippuric acid as tracer for GCBF, 1976
12 48
Series KSM1 -- KSM3: methylglucose as tracer for GCBF, 1975
 
Lidocaine (Lido) series, 1978-1979
12 49
Lido-1, 7/24/78, control
12 50
Lido-1', 7/24/78
12 51
Lido-2, 8/3/78
12 52
Lido-3, 8/10/78, 2 lidocaine
12 53
Lido-4, 8-10-78, 1 lidocaine
12 54
Lido-5, 1-11-79, saline control
12 55
Lido-5', 1-11-79, no seizure history
12 56
Lido-6, 1-12-79, saline
12 57
Lido-6', 1-12-79, lidocaine
12 58
Lido-7, 1-19-79, saline
12 59
Lido-7', 1-19-79, lidocaine
12 60
Lido-8, 1-25-79, saline
12 61
Lido-8', 1-25-79, lidocaine
12 62
Lido-9, 1-26-79, saline
12 63
Lido-9' (experimental animal) 1-26-79
12 64
Lido-10, 2-1-79, saline control
12 65
Lido-10', 2-1-79, lidocaine
12 66
Lido-11, 2-2-79, saline control
12 67
Lido-11', 2-2-79, lidocaine
12 68
Lido-12, 2-15-79, saline
12 69
Lido-12', 2-15-79, lidocaine
12 70
Lido-13, saline, 2-16-79
12 71
Lido-13', lidocaine, 2-16-79
12 72
Lidocaine summary, 1979
 
Glucose Utilization (LCGU) series, 1977-1987
12 73
Cerebral structure w/ signif. changes in LCGU at higher doses of D-LSD, 1976-1977
12 74
Effects of LSD on LCGU in individual structures as a function of dose, n.d.
12 75
Experiments -- hyperglycemia R.C. average, 1984
12 76
Free moving immobilization on LCGU and LCBF, 1978
12 77
Glucose / LCGU : from 0' -- 120', n.d.
12 78
Hyperglycemia LCGU experiments -- excluded and misc. [folder 1 of 2], 1980-1982
13 1
Hyperglycemia LCGU experiments -- excluded and misc. [folder 2 of 2], 1980-1982
13 2
Hyperglycemia LCGU experiments -- used and tables, 1982
13 3
Hyperglycemia LCGU experiments 450, 1984
13 4
Hyperglycemia LCGU experiments 450 (programming changes), 1984
13 5
Hyperglycemia LCGU experiments 550A, 1984
13 6
Hyperglycemia, 2DG, 450's, 1984
13 7
L.C.G.U. (pulse exp.) parameters: new 3 rate constants, 1986
13 8
L.C.G.U. (pulse experiments) from Dr. Shinohara's data representative structures, 1977
13 9
LCGU -- pulse experiments -- LC=0.483 -- parameters: new 3 rate constants, 1986
13 10
LCGU -- sandro, n.d.
13 11
LCGU -- taro, n.d.
13 12
LCGU (pulse experiments) -- 5 rate constants (K4*=0.002), 1986
13 13
LCGU (pulse experiments) Shinohara series -- graphs -- representative structures, 1977
13 14
LCGU (pulse) parameters 5 rate constants (K4*=0.0014), 1986
13 15
LCGU (square exp.) parameters 5 rate constants (K4*=0.001), 1986
13 16
LCGU (square wave experiments) graphs, n.d.
13 17
LCGU (square wave experiments) gray structures, n.d.
13 18
LCGU (square wave experiments) white structures, n.d.
13 19
LCGU hyperglycemia experiments -- Franz, Francesco, 1980
13 20
LCGU pulse experiments -- 5 rate constants (K4*=0.001), 1986
13 21-23
Local Cerebral Glucose Utilization, 1987
13 24
Shinohara pulse data -- LCGU w/5 -- H model -- K4=.002, K5=.05, 1986
13 25
Spinal cord (sleep) -- LCGU, n.d.
13 26
Summary of LCGU (pulse) with original rate constants, 1987
13 27
Summary of local LCGU -- square wave exp., n.d.
13 28
Table for LCGU value, n.d.
13 29
The effect of NMA on LCGU in the rat, n.d.
13 30
Weighted average LCGU -- pulse experiments, n.d.
 
LS series, 1977-1979
14 1
LS-11, general, 8-29-78
14 2
LS-II-1, 1977
14 3
LS-II-2, 11-8-77
14 4
LS-II-3, 11-8-77
14 5
LS-II-4, 11-8-77
14 6
LS-II-5, 11-10-77
14 7
LS-II-6, 11-11-77
14 8
LS-II-7, 11-11-77
14 9
LS-II-8, 12-9-77
14 10
LS-II-9, 12-9-77
14 11
LS-II-10, 12-9-77
14 12
LS-II-11,12,13, 2-24-78
14 13
LS-II-14,15,16, 4-3-78
14 14
LS-II-17, 4-7-78
14 15
LSB-2, 1979
14 16
LSB-3, 1977
14 17
LSB-4, 1977
14 18
LSB-5, 1977
14 19
LSB6-10, 1977
 
MG series, 1973, 1988-1989
14 20
Extracting rat brain containing 3H-MG with hexane and chloroform by H. Nakanishi, 1988-1989
14 21
HIGH std.-2, 14c-MG, 10-2-78
14 22
HIGH-STD-3, 14c-MG, 10-2-78
14 23
MG and hypothalam atlas [computer disk], n.d.
14 24
MG series '73, 1973
14 25
MG-1, 5' cont., 1973
14 26
MG-2, 10' -- cont., 1973
14 27
MG-3, 20' -- cont., 1973
14 28
MG-4, 30' -- cont., 1973
14 29
MG-5 (C14), 2 hrs., 1973
14 30
MG-6 (C14), 1 min., 1973
14 31
MG 7 (C14), 15' cont., 1973
14 32
MG-8 (C14), 60' cont., 1973
14 33
MG-9, 45' cont., 1973
14 34
MG-10 (C14), 4' -- cont., 1973
14 35
MG-11 (C14), 45' -- cont., 1973
14 36
MG-12 (C14), 40' -- bol. C.S.F., 1973
14 37
MG-13 (C14), 4' -- cont., 1973
14 38
MG-14 (C14), 50' -- bol. C.S.F., 1973
14 39
MG-15, 75' -- bol. C.S.F., 1973
14 40
MG-16, 120' -- bol. C.S.F., 1973
14 41
MG-17, 60' -- bol. C.S.F., 1973
14 42
MG-18, 240' -- bol. C.S.F., 1973
14 43
MG-101 and 102, 30' -- B -- 51 u., 1973
14 44
MG-103 and 104, 45' -- B -- 76 uc., 1973
14 45
MG-105, B -- 120' -- 51 uc., 1973
14 46
MG-106 and 107, B - 45' -- 51 uc., 1973
14 47
MG-108, B -- 120' -- 51 uc., 1973
14 48
MG-109 and 110, B -- 60 -- 51 uc., 1973
14 49
MG-111 and 112, B -- 75' -- 51 uc., 1973
14 50
MG-113 and 114, B -- 90' -- 51 uc., 1973
 
MSG series, 1978
14 51
MSG-01, 6-22-78
14 52
MSG-03, 7-10-78
14 53
MSG-04, 7-11-78
14 54
MSG-05, 7-11-78
14 55
MSG-06, 7-12-78
14 56
MSG-07, 7-12-78 (experiment stop)
14 57
MSG-1, 1-11-78
14 58
MSG-2, 2-7-78
14 59
MSG-3, 2-13-78
14 60
MSG-4, 2-25-78
14 61
MSG-5, 4-4-78
14 62
MSG-6, 4-18-78
14 63
MSG-7, 5-3-78
 
NA24 series, 1956-1957
14 64
Bankson, Frederick N.C. -- LBF -- Na24, 1956
14 65
Binkley, Linda N.C. -- LBF -- Na24, 1956
14 66
Brandt, Mildred N.C. -- LBF -- Na24, 1957
14 67
Buck, Jean PN -- LBF -- Na24, 1956
14 68
Busenitz, Donald N.C. -- LBF -- Na24, 1956
14 69
Dunmeyer, Lloyd, M.Dy. -- LBF -- Na24, 1956
14 70
Flickner, Irma N.C. -- LBF Na24, 1957
14 71
Goosen, Warren N.C. -- LBF -- Na24, 1956
14 72
Grim, Nancy N.C., 1957
14 73
Johnson, James M.Dy. -- LBF -- Na24, 1957
14 74
Kelley, Edward M.Dy. -- LBF -- Na24, 1957
14 75
Kidder, Helen PN -- LBF -- Na24, 1956
14 76
Merediz, Laura M.Dy. -- LBF -- Na24, 1956
14 77
Merkey, Phoely N.C. -- LBF -- Na24, 1957
14 78
NA24, 1954
14 79
Na24 -- leg blood flow studies, 1956
14 80
Na24 -- leg blood flow studies -- book 2, 1957
14 81
Peters, A. Joan M.Dy. -- LBF -- Na24, 1957
14 82
Peters, B. Jean M.Dy. -- LBF -- Na24, 1957
14 83
Smith, Ivan N.C. -- LBF -- Na24, 1957
14 84
Steider, Kenneth -- LBF -- Na24, 1956
14 85
Tillman, Joseph P. N. -- LBF -- Na24, 1956
14 86
Wells, John Sch. -- LBF -- Na24, 1956
14 87
Williams, Esther N.C. -- LBF -- Na24, 1956
14 88
Wingert, John N.C. -- LBF -- Na24, 1956
 
New born monkey (NBM) series, 1970-1979, 1983-1989
14 89
Assay of monkey blood, 1978
14 90
LCM 6, 9-30-76
14 91
LCM-7, 10-14-76
14 92
LCM 9, 11-18-76
14 93
Monkey K-732-1, 1971
14 94
Monkey K739-2, 1971
14 95
Monkey lumped constant study, no. 1 [photograph], 1976
14 96
Monkey lumped constant study, no. 2, 1976
14 97
Monkey lumped constant study, no 3, 1976
14 98
Monkey lumped constant study, no 4, 1976
14 99
Monkey lumped constant study, no. 5, 1976
14 100
Monkey-control -- misc., 1985-1989
14 101
NBM-101, tarsoraphy at. 2 days, 1976-1985
14 102
NBM-2, rt. eye patched (LCGU) 11-24-78
14 103
NBM-3, LCGU 3, 1976-1977
14 104
NBM-4 [diskette], 1983
14 105
NBM4, new born monkey, LCGU-control, 1976
14 106
NBM-5, 3-15-76 (LCGU control)
15 1
NBM-6, LCGU, 3-22-76
15 2
NBM7 (new born monkey control), 1976
15 3
NBM-8, LCGU-30', r. eye patched, 1978
15 4
Newborn monkey, LCGU control (NBM1), 1976
15 5
PEN. SEIZ.: adult monk. controls + experimentals, 1970
15 6
PEN. SEIZ.: newborn monk. experimentals, 1970
15 7
PEN. SEIZ: newborn monkeys controls, 1970
15 8
Pen-C, 1, 1975
15 9
Series S.M.: laplace transform, 2-DG conscious monkeys, 1976
15 10
Statist. -- new born monkey, 1979
15 11
Stimulated monkey -- summary tables and graphs, n.d.
 
PCP series, 1986-1987
15 12
PCP-1 -- 10 mg/kg, 1986
15 13
PCP - 2 Saline 0.36, 1986
15 14
PCP - 3 1 mg/kg, 1988
15 15
PCP - 4 N. Saline, 1986
15 16
PCP - 5 0.3/kg, 1986
15 17
PCP- 6 3mg/kg, 1986
15 18
PCP - 7 1mg/kg, 1987
15 19
PCP - 8 0.1mg/kg, 1987
15 20
PCP - 9 10mg/kg, 1987
15 21
PCP- 10 N.S., 1988
15 22
PCP - 11 3mg/kg, 1986
15 23
PCP - 12 0.3mg/kg, 1986
15 24
PCP - 13 1mg/kg, 1987
15 25
PCP - 14 0.1mg/kg, 1987
15 26
PCP - 15 3.0mg/kg, 1987
15 27
PCP - 16 N.S., 1987
15 28
PCP - 17 0.3mg/kg, 1986
15 29
PCP - 18 10mg/kg, 1986
15 30
PCP - 19 N.S., 1986
15 31
PCP - 20 0.1mg/kg, 1987
15 32
PCP - 21 0.3/kg, 1987
15 33
PCP 21-2, 1987
15 34
PCP - 22 3mg/kg, 1987
15 35
PCP - 23 10mg/kg, 1987
15 36
PCP - 24 N.S., 1987
15 37
PCP - 25 1mg/kg, 1986
15 38
PCP - 26 10mg/kg, 1987
15 39
PCP 27 0.3mg/kg, 1987
15 40
PCP 28 0.1mg/kg, 1988
15 41
PCP Data, 1987
15 42
PCP Raw Data, 1986
 
PT series, 1949-1950, 1979-1987
15 43
PT series -- scp*(t)/cp* - scp*dt/T, 1949-1950
15 44
Pulse 2DG experiments -- PT series -- Ken Mori StCp*(t)dt, 1986
15 45
PT series plus experiments -- physiological conditions, 1987
15 46
Summary PT series -- stretch time etc., pulse exp. mori, 1979-1986
15 47
PT-2 -- 60 min. -- July 25, 86, 1980-1986
15 48
PT-6 -- 35 min. -- July 26, 86, 1980-1986
15 49
PT-7 -- 120 min. -- Aug. 4, 86, 1980-1986
15 50
PT-8 -- 60 min. -- Aug. 4, 86, 1980-1986
15 51
PT-9 -- 25 min. -- Aug. 4, 86, 1980-1986
15 52
PT-10 -- 90 min. exp. -- Aug. 5, 86, 1980-1986
15 53
PT-11 -- 35 min. exp. -- Aug. 5, 86, 1980-1986
15 54
PT-12 -- 45 min. exp. -- Aug. 5, 86, 1980-1986
15 55
PT-13 -- 120 min. exp. Aug. 86, 1980-1986
15 56
PT-14 -- 60 min. -- Aug. 6, 86, 1980-1986
15 57
PT-15 -- 25 min. -- Aug. 6, 86, 1980-1986
15 58
PT-16 -- 90 min. exp. -- Aug. 7, 86, 1980-1986
15 59
PT-17 -- 45 min. exp. -- Aug. 7, 86, 1980-1986
15 60
PT-18 -- 35 min. exp. -- Aug. 7, 86, 1980-1986
15 61
PT-20 -- 60 min. exp. -- Aug. 8, 86, 1980-1986
15 62
PT-21 -- Aug. 8, 86, 1985-1986
15 63
PT 22 -- 120 min. exp. -- Aug. 11, 86, 1980-1986
15 64
PT 23 -- 90 min. exp. -- Aug. 11, 86
15 65
PT 24 -- 4-5 min. exp. -- Aug. 11, 86
15 66
PT-25 -- 120 min. exp. -- Aug. 13, 86, 1985-1986
15 67
PT-26 -- 90 min. exp. - Aug. 13, 86
15 68
PT-27 -- 35 m in. exp. -- Aug. 13, 86, 1985-1986
15 69
PT-28 -- 45 min. exp. -- Aug. 14, 86, 1985-1986
15 70
PT-29 -- 25 min. exp. -- Aug. 14, 86, 1985-1986
15 71
PT-31 -- 25 min. -- Nov. 17, 86, 1985-1986
15 72
PT-32 -- 90 min. -- Nov. 18, 86
15 73
PT-33 -- 25 min. -- Nov. 18, 86, 1985-1986
15 74
PT-34- 45 min. exp. -- Nov. 24, 86, 1985-1986
15 75
PT-35 -- 35 min. exp. -- Nov. 24, 86, 1985-1987
15 76
PT-36 -- 35 min. -- Nov. 24, 86, 1985-1987
15 77
PT-37 -- 45 min. -- Nov. 25, 86, 1985-1987
15 78
PT-38 -- 35 min. -- Nov. 25, 86, 1985-1987
15 79
PT-39 -- 45 min. exp. -- Nov. 26, 86, 1985-1986
15 80
PT-40 -- 25 min. exp. -- Nov. 26, 86, 1985-1986
15 81
PT-41 -- 25 min. exp. -- Nov. 26, 86, 1985-1986
15 82
PT-42 -- 60 min. exp. -- Nov. 28, 86, 1985-1986
15 83
PT-43 -- 35 min. exp. -- Nov. 28, 86, 1985-1987
15 84
PT-44 -- 45 min. exp. -- Nov. 28, 86, 1985-1987
15 85
PT series -- parameters with new three rate constants -- K1*=0.232, K2*=0.240, K3*=0.061, 1985-1986
 
PX series, 1978
15 86
PX-0 (.42 mg/kg), 5-3-78
15 87
PX-01 (.42 mg/kg), 8.21.78
15 88
PX-02 (.42 mg/kg), 8-21-78
15 89
PX-1 (21 mg/kg, 8.6 mg pulse), 2-8-78
15 90
PX-2 (7.8 mg pulse), 2-29-78
15 91
PX-3 (8.5 mg pulse), 2-29-78
15 92
PX-4 (21 mg/kg, 8.2 mg pulse), 3-15-78
16 1
PX-5 (4.2 mg/kg), 3-30-78
16 2
PX-6 (4.2 mg/kg), 3-30-78
16 3
PX-7 (4.2 mg/kg), 4-5-78
16 4
PX-8 (4.2 mg/kg), 4-12-78
16 5
PX-9 (42 mg/kg), 4-12-78
16 6
Px-10, 4-19-78
16 7
Px-11, 4-19-78
16 8
PX-12 (4.2 mg/kg), 4-27-78
16 9
PX-13 (4.2 mg/kg), 5-9-78
16 10
PX-14 (42 mg/kg), 5-9-78
16 11
PX-15 (4.2 mg/kg), 8-21-78
16 12
PX-16 (21 mg/kg), 8-21-78
16 13
PX-17 (42 mg/kg), 8-25-78
16 14
PX-18 (9 mg/kg), 12-10-78
16 15
PX-19 (9 mg/kg), 12-10-78
16 16
PX-20 (9 mg/kg), 12-11-78
16 17
PX-21 (9 mg/kg), 12-22-78
16 18
PX-22 (9 mg/kg), 12-13-78
 
SM series, 1973-1985
16 19
SM-1, B-45'-320 ul -- rt. eye covered and wurtz, 1975
16 20
Series SM-2: unilateral patching, 1973
16 21
SM-2A, B'-45'-100 uc, both eyes opened, 1973-1978
16 22
SM-3, P-45'-250 uc. (rt. eye patched), 1973-1975
16 23
SM-3A, visual: rt. eye removed, P-45'-250 uc, 1973-1975
16 24
SM-4A, both eyes opened and wurtz pattern - P-45'-300 uc, 1973-1975
16 25
Series SM-5: both eyes patched, 1975
16 26
SM-6, 45'-300 mc -- both eyes patched, 1974-1975
16 27
Series SM-7: eyes intact + stimulation, 1974
16 28
SM-8A, 1974-1977
16 29
Series SM-9A: eyes intact + stimulation, 1975-1977
16 30
SM-10, both eyes intact and wurtz pattern, 1974-1975
16 31
SM-11, 1978
16 32
SM-11, both eyes intact and wurtz, pattern, 1974-1977
16 33
Series SM-12: eyes intact + stimulation, 1974-1977
16 34
SM-13, left eye removed and wurtz, 1974
16 35
SM-14, 5-1-75, rt. eye removed and ambient light
16 36
Series SM-15: unilateral enucleation, 1975
16 37
Series SM-16: unilateral enucleation, 1975
16 38
SM-17, 8-7-75 -- left eye patched and wurtz
16 39
Series SM-18: unilateral enucleation
16 40
SM-19, 11-6-75 -- left eye patched and wurtz
16 41
SM-20, 11-20-75 -- left eye patched and wurtz
16 42
SM-21, Dec. 23, 1975 -- rt. eye patched and wurtz [photograph]
16 43
SM-22, Dec. 23 '75 -- left eye removed and wurtz
16 44
SM-23, Jan. 23 '76 -- both eyes open
16 45
SM-24, both eyes patched, Feb. 5 '76
16 46
SM-25, 2-19-76 -- rt. eye patched and wurtz
16 47
SM-26, 3-19-76 -- rt. eye patched and wurtz
16 48
SM-27, 5-28-76 -- both eyes opened and wurtz
16 49
SM-28, Aug. 2 '76
16 50
SM-29, 11-4-76
16 51
SM-30, 12-9-76
17 1
SM-31, 1976-1985
17 2
SM-32, 1-18-77
17 3
SM33 and SM24, densitometry, n.d.
17 4
SM-33, 8-4-77, both eyes occluded
17 5
SSM-1/SSM-3, n.d.
17 6
SSM-2, 1979
17 7
SSM-2, 4-7-77 [diskette]
17 8
SSM-4 (rt. optic tract sectioned), 1977
17 9
SSM-4 [diskette], 1979
 
SR series, 1973-1974
17 10
Series SR-1: visual alterations, 1973
17 11
Series SR-1A: visual alterations, 1973
17 12
Series SR-2: visual alterations, 1973
17 13
Series SR-2A: visual alterations, 1973
17 14
Series SR-3: visual alterations, 1973
17 15
Series SR-3A: visual alterations, 1973
17 16
SR-3B (l. eye remove), 1973
17 17
SR-4-I (r-eye remove), 1973
17 18
SR-4-II (l-eye remove), 1973
17 19
S.R.-5, (left eye patched, TOT -- darkness, I.P.S.), 1973
17 20
Series SSR: sciatic nerve stimulation, 1974
 
Thyroxine series
17 21
Reprints -- thyroxine, 1956
17 22
Summaries of thyroxine mitochondrial factor studies, 1964-1965
17 23
Summaries thyroxine effects on pyridine nucleotides, 1975
17 24
T4 effect on mitochondrial NAD+, 1970
17 25
Thyroxine -- illustrations [photographs, negatives], n.d.
17 26
Thyroxine -- protein synthesis, 1955-1965
17 27
Thyroxine -- protein synthesis in vivo, 1963-1964
17 28
Thyroxine -- uptake by brain, 1954-1955
17 29
Thyroxine analogues [photographs, negatives], 1963
17 30
Thyroxine effects on NAD+, 1974
17 31
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 1 of 3], 1974-1975
17 32
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 2 of 3], 1974-1975
17 33
Thyroxine effects on pyridine nucleotides -- amino-chance scans [folder 3 of 3], 1974-1975
17 34
Thyroxine effects on pyridine nucleotides, 1974
17 35
Thyroxine experiments, 1964
18 1
Thyroxine experiments -- book 2, 1957-1958
18 2
Thyroxine experiments -- book 3, 1958
18 3
Thyroxine factor [negatives], n.d.
18 4
Thyroxine iodine studies, 1954-1955
18 5
Thyroxine mechanism -- tables and illus. [photographs, negatives], n.d.
18 6
Thyroxine project -- charts and slides [photographs, negatives], n.d.
18 7
Thyroxine project -- charts and slides [photographs, negatives], n.d.
18 8
Thyroxine solutions, 1959-1964
18 9
Thyroxine solutions II, 1965-1972
18 10-12
Thyroxine-mitochondrial factor -- preparations and properties -- book 1, 1966-1968
 
Whisker barrel (WB) series, 1991-1993
18 13
WB i.v. study, statistics, 1992
18 14
01 whisker barrel series: control, 1991
18 15
WB-02 experiment NMA 30 mg/kg, 1991
18 16
WB-03 control, 1991
18 17
WB-04, control, 1991
18 18
WB-05, experiment NMA 30 mg/kg, 1991
18 19
WB-06, exp. normal saline 1.1 ml, 1991
18 20
WB-07, exp. NMA 30 mg/kg, 1991
18 21
WB-08, exp. NMA 30 mg/kg, 1991-1992
18 22
WB-09, control, 1991
18 23
WB-09, control, 1991
18 24
WB-11, exp. NMA 30 mg/kg, 1991
18 25
WB-12, NMA 100 mg/kg, 1991
18 26
WB-13, NMA 100 mg/kg, 1991
18 27
WB-14, NMA 100 mg/kg, 1991
18 28
WB-15, NMA 100 mg/kg i.v., 1991
18 29
WB-16, control (saline + no stimulation), 1991
18 30
WB-17, NMA 30 mg/kg i.v., 1991-1992
18 31
WB-18, control, 1991-1992
18 32
WB-19, saline i.v. + no stimulation, 1991
18 33
WB-20, control, 1991
18 34
WB-21, control, 1991-1992
18 35
WB-22, methyl ester, 1992
18 36
WB-22, methyl ester 30 mg/kg i.v., 1992
18 37
WB-24, control, 1992
18 38
WB-25, NAME, 1992
18 39
WB-26, control (saline i.v. and no stimulation), 1992
18 40
WB-27, NAME, 1992
18 41
WB-28, control, 1992
18 42
WB-29, control, 1992
18 43
WB-30, nitro-L-arginine methylester, 1992
18 44
WB-31, control, 1992
18 45
WB-32, nitro-L-arginine methylester, 1992
18 46
WB-33, NAME, 1992
18 47
WB-34, control, 1992
18 48
WB-35, nitro-L-arginine methylester, 1992
18 49
WB-36, nitro, fast infusion, 1992
18 50
WB-37, control, 1992
18 51
WB-38, nitro-L-arginine M.E., 600 ug/rat, 1992
18 52
WB-39, control (DIR), 1992
18 53
WB-40, nitro (direct), 600 ug/rat, 1992
18 54
WB-41, control (direct), 1992
18 55
WB-42, nitro-L-arginine (direct), 1992
18 56
WB-43, nitro-L-arginine, 600 ug/rat, 1992
18 57
WB-44, control, 1992
18 58
WB-45, nitro-L-arginine, 600 ug/rat, 1992
18 59
WB-46, nitro-L-arginine, 600 ug/rat, 1992
18 60
WB-47, control, 1992
18 61
WB-48, control, 1992
18 62
WB-49, nitro-L-arginine, 600 ug/rat, 1992
18 63
WB-50, control, 1992
18 64
WB-51, nitro-L-arginine, 600 ug/rat, 1992
18 65
WB-52and53, 3H-nitro-L-arginine and intracisternal infusion, 1993
18 66
WB-54, chronic and NAME, 1993
18 67
WB-55, chronic i.p. and NAME, 1993
18 68
WB-56, chronic ad of NAME, 1993
18 69
WB-57, chronic i.p., 1993
18 70
WB-58, chronic i.p., 1993
18 71
WB-59, chronic i.p., 1993
18 72
WB-60, L-NAME chronic i.p., 1993
18 73
WB-61, chronic i.p., 1993
18 74
WB-62, chronic i.p., 1993
18 75
WB-63, saline chronic i.p., 1993
18 76
WB-64, saline chronic i.p., 1993
18 77
WB-65, saline chronic i.p., 1993
18 78
WB-66, saline chronic i.p., 1993
19 1
WB-cisternal infusion, 1992
19 2
WBDG -- DG parity check, 1992
19 3
WBDG-1, 1992
19 4
WBDG-2, 1991-1992
19 5
WBDG-3, 1991-1992
19 6
WBDG-4, 1992
19 7
WBDG-5, 1992
19 8
WBDG-6, 1992
19 9
WBDG-7, 1992
19 10
WBDG-8, 1992-1993
 
YOH series, 1978
19 11
YOH-1 (.25 mg/kg/min.), 4-5-78
19 12
YOH-3 (.25 mg/kg/min.) 7-10-78
19 13
YOH-4 (.25 mg/kg/min.), 7-10-78
19 14
YOH-5 (.1 mg/kg/min.), 7-11-78
19 15
YOH-6 (.25 mg/kg/min.), 7-11-78
19 16
YOH-7 (.1 mg/kg/min.), 7-11-78
19 17
YOH-10 (.25 mg/kg/min.), 8-19-78
19 18
YOH-11 (.1 mg/kg/min.), 8-30-78
19 19
YOH-12 (.25 mg/kg/min.), 9-8-78
19 20
YOH-13 (.25 mg/kg/min.), 9-8-78
19 21
YOH-14 (.25 mg/kg/min.), 9-8-78
19 22
YOH-15 (.025 mg/kg/min.), 9-18-78
19 23
YOH-16 (.025 mg/kg/min.), 9-18-78
19 24
YOH-17 (.1 mg/kg/min.), 12-14-78
19 25
YOH-18 (.1 mg/kg/min.), 12-14-78
19 26
YOH-19 (.05 mg/kg/min.), 12-15-78
19 27
YOH-20 (.05 mg/kg/min.), 12-15-78
19 28
YOH-21 (.05 mg/kg/min.), 12-18-78
19 29
YOH-22 (.05 mg/kg/min.), 12-18-78
19 30
YOH-23 (.05 mg/kg/min.), 12-19-78
19 31
YOH-24 (.0025 mg/kg/min.), 12-20-78
19 32
YOH-25 (.025 mg/kg/min.), 12-20-78
19 33
YOH-26 (.025 mg/kg/min.), 12-20-78
19 34
YOH-27 (.0025 mg/kg/min.), 12-21-78
19 35
YOH-28 (.0025 mg/kg/min.), 12-21-78
19 36
YOH-29 (.0025 mg/kg/min.), 12-21-78
 
Other experiments, 1952-2003
19 37
1. aging -- CBF -- Normal, 1955-1957
19 38
2. aging -- CBF -- hypertension, 1956
19 39
3. aging -- CBF -- arteriosclerosis, 1956-1957
19 40
4. aging -- CBF -- chronic brain syndrome, 1957-1958
19 41
B. aging -- patient material, 1957-1959
19 42
C. Aging - Statistics, 1958-1959
19 43
C. Aging - Statistics, 1959
19 44
D Aging - Inter Correlations, 1959-1960
19 45
E Aging -- research data, 1959-1960
20 1
ANES series, 1993
20 2
ANES 1-5, Jan. 5-11, 1993
20 3
ANES 6-10, Jan. 12-25,1993
20 4
ANES 11-15, Feb. 1-9, 1993
20 5
ANES 16-20, Feb. 16-23, 1993
20 6
ANES 21-25, March 21-31, 1993
20 7
ANES 26-30, March 9-22, 1993
20 8
ANES31-34, March 23-28, 1993
20 9
ANES, 1992
20 10-11
Arterial curves -- O2 -- C02 series, 1956
20 12-13
Arterial curves -- SCL series [photographs], 1956
20 14
CE-1: lumped constant rat, 5%, CO2 inhal, 1974
20 15
CE-2: lumped constant rat, 5% CO2 inhal., n.d.
20 16
CE-3: lumped constant rat, 5% CO2 inhal., 1975
20 17
CE-4: lumped constant rat, 5% CO2 inhal., 1975
20 18
CK1, 60 min. normal control, 6-15-78
20 19
CK2, 60 min. 6-15-78
20 20
CS-23, 7-10-78
20 21
CS-24, 8-21-78
20 22
CS-26, 12-13-78
20 23
CS-27, 12-14-78
20 24
G5 Ur W5 V4 original rate constants, n.d.
20 25
Parameters (V4 V4 G6 W5) pulse experiments -- new 3 rate constants, 1985
20 26
HYP1 (10%), 1-15-76
20 27
HYP2 (10%), Jan. 15, '76
20 28
HYP-3 (7.5% O2), Jan. 21, '76
20 29
HYP-4 (7.5% O2), Jan. 21, '76
20 30
Hypoxia 10% O2 behavior: observation, 1976
20 31
LCBF summary, n.d.
20 32
LCBF summary for misc. data, n.d.
20 33
Sheet for LCBF, n.d.
20 34
1 washout constant exp., flow rate: 0.8 ml/min., 1991
20 35
2 washout constant exp., flow rate: 1.0 ml/min., 1991
20 36
03 washout constant exp., flow rate: 1.2 ml/min., 1991
20 37
04 washout constant exp., flow rate: 0.6 ml/min., 1991
20 38
05 washout constant exp., flow rate: 1.4 ml/min., 1991
20 39
06 washout constant exp., flow rate: 1.6 ml/min., 1991
20 40
Washout correction for LCBF equation, n.d.
20 41-42
Wynn project -- alleged non-mitochondrial thyroxine stimulation of protein synthesis -- Nov. 9, 70, 1970
20 43
2 Deoxyglucose Studies (Rat, Cat), 1973-1983
20 44
2.5 min., n.d.
20 45
5.0 min., n.d.
20 46
10 min., n.d.
20 47
15 min., n.d.
20 48
30 min., n.d.
20 49
45 min., n.d.
20 50
60 min., n.d.
20 51
90 min., n.d.
20 52
120 min., n.d.
20 53
14C Toluen internal std. -- lot 0060283A, 1986
20 54
14c-warfarin, 1993
20 55
Abrams -- lumped constant data, 1985
20 56
Additional structure morphine, n.d.
20 57
Alfred Benzon symposium, 1990
20 58
Amanda, 12-5-79, 1979
20 59
Amersham standard calibration, 1978
20 60
Analytical ultracentrifuge records [photographs], 1966
20 61
Anesthesia record, n.d.
21 1
Animal phosphate [photographs], 1978
21 2
AP vs. IAP rat summary, n.d.
21 3
Arithmetic mean value of gray structures (pulse experiments), 1979
21 4
Arterial blood studies (Tbl 1) (from Reivitch, et. al.) [slides], 1977
21 5
Astroglial exp. -- amino acid analysis key, 1995
21 6
Astroglial exp. -- Dr. Kaufman's cell extract samples, 1995
21 7
Astroglial exp. -- intracellular A.A., 1995
21 8
Atlas -- 1, 1980
21 9
Amino-acid-analyzen, 1992
21 10
A. V. blood curves -- desaturation curves studies, 1952-1956
21 11
Banzo (sleep control), 1980
21 12
Basil, 6/13/79
21 13
Beckman polygraph calibration, n.d.
21 14
Blank sheets for experiments, n.d.
21 15
Crop, 6-25-79
21 16
Brain development, n.d.
21 17
Bonzo, film 21, 1985
21 18
Brain -- (Gelber) photos and negatives [photographs, negatives], 1967
21 19
Calibration of plastic standards, 1969-1975
21 20
Calibration of standards, n.d.
21 21
Calibration standards using the "10" and "new low" standards, 1986
21 22
Catheter -- calibration exp., 1991-1992
21 23
Catheter smear collection, n.d.
21 24
Caveness study materials [photographs], n.d.
21 25
CCK -- vagotomized, 1980
21 26
Chico, 1980-1984
21 27
Chr. Li-1, 5-27-80
21 28
Chronic -- nitro i.p., 1993
21 29-30
Chronic i.p. of L-NAME series vol. 1-2, 1993
21 31
Clinical trials of barbiturates in rats, 1972
21 32
Collaboration -- Bill Eckelman and Juntendo Univ., 1999
21 33
Collaboration -- Dr. David M. Cohen, 2000-2003
21 34
Collaboration -- Dr. Rolf Gruetter -- Univ. of Minnesota, 1999-2001
21 35
Collaboration -- SuperGen, 1999-2000
21 36
Dee, film 8-35, 1978
21 37
Dee, film no. 7-35, 1979
21 38-39
Densitometric calibration curves, 1953-1955
21 40
Densitometry 1, 1953-1954
21 41
Densitometry 2, 1954
22 1
Deoxyglucose review, 1980-1981
22 2
Directories -- disk and tape, 1985
22 3
Discarded animals, 1972
22 4
Dreamless, film 17, n.d.
22 5
Dreamless, 1980
22 6
ECF mixed culture (counting data), 1995
22 7
ECG, EOG and EMG (from Reivitch, et. Al.) [Slides], 1985
22 8
Effects of barbiturates on blood gases, n.d.
22 9
Effects of epinephrine on blood glucose, 1958-1959
22 10
Equilibrium, n.d.
22 11
ER-M, C-31'-236 uc., 1973-1974
22 12
Exp. CC1, 1980
22 13
Exp. CC2, 1980
22 14
Exp. CC5, 1980
22 15
Exp. CR2, 1980
22 16
Exp. CR3, 1980
22 17
Exp. CR4, 1980
22 18
Exp. CR6, 1980
22 19
Exp. CR7, 1980
22 20
Experiment 6: raw data -- nucleotide separation by high voltage electrophoresis, 1970
22 21-22
Factor preparation and properties -- book 2, 1968-1974
22 23
Factor TLC scans, 1969
22 24
Failed experiment, Aug. 22, 1991, 1991
22 25
G5 U4 with new 3 rate constants -- Ki*=.232, K2*=.240, K3*=0.61, 1985
22 26
GEE -- experiment work sheep, 1978-1979
22 27
GEE file no. 7-33, 1979-1980
22 28
Glucose deter.: Beckman vs. Gilford, 1975
22 29
Glucose deter.: with glass vs. Eppendorf pipets, 1975
22 30
Glucose determination (spectrophotometer), n.d.
22 31
Glucose determination: glucose oxidase method, n.d.
22 32
Glucose determination: miscellaneous, 1973-1975
22 33
GU-BMF (multi-film program), n.d.
22 34
Guide to reading auto radiographs, n.d.
22 35
Hemoglobinometry, 1979
22 36
HG misc., 1980
22 37
High-std-1, 14c meth. Glucose, 1978
22 38
History: rat thyroidectomies, 1960-1966
22 39
Hydroxybuty rate assay, 1969
22 40
Hyperinsulinemia experiments, 1980
22 41
Info. on micropipettes and pumps, 1973
22 42
Insulin hypoglycemia (50 uci/animal), n.d.
22 43
Internal standard, 1985
22 44
L.S. brain -- I, 1977
22 45
Laplace transform -- technical info., 1975
22 46
Liquid scintillation media, 1974
22 47
List of research projects planned, n.d.
22 48
Low standard I graph, 1977
22 49
LSD-DG series, 1975-1976
22 50
M. Shionohara -- summarized date, 1979
22 51
Manuscript -- Dr. Sokoloff [photographs], n.d.
22 52
Marburg slides, n.d.
22 53
Mean weighted average (GU) -- square exp. (GU was calculated with weighted average of tissue conce.), 1979
22 54
Mean weighted average of GU (GU was directly calculated by image processor), n.d.
22 55
Metabolic maturation of the brain in relation to asphyxia neonatorum, 1963-1964
22 56
Milt, 6-14-79, 1979
22 57
Milt, film no. 1-32, 1979-1982
22 58
Misc. papers, 1979-1980
22 59
Miscellaneous statistical analyses, 1960
22 60
Mixed and astroglial culture, 1995
22 61
Morphine summary, n.d.
22 62
MTZ-1, Dec. 1, 1975
22 63
MTZ-2, Dec. 2, 1975
22 64
N.E.N. standard calibration, 1978-1979
23 1
NH3 - 1-3, HF - 1-2, GD - 1-3, DLX, DX 1-4 Rats [ X- Rays], 1977
23 2
N.O.S. assay, 1992-1993
23 3
Nitro i.p. -- enzyme assay, 1993
23 4
No synthase assay, 1992-1993
23 5
NOD, 3-18-80
23 6
Nodoz, 4-8-80 [photographs]
23 7
Nodoz, film 6, 1980
23 8
NOS activity after nitroarginine intracisternal infusion, 1993
23 9
Nose, 3-22-79
23 10
OD vs. con. x time, n.d.
23 11
Olf. Bulb, n.d.
23 12
Original 3-rate constants, 1986
23 13
Parameters (pulse experiments ) 5 rate constants (K4*=0.0014), 1986
23 14
Parameters (pulse experiments) -- 5 rate constants (K4*=0.002), 1986
23 15
Parameters (square exp.) 5 rate constants, 1986
23 16
Parsley, 7-10-80
23 17
Phosphate, 1979
23 18
Phosphate, 1978
23 19
Physiological conditions' summary -- pulse exp., n.d.
23 20
Plasma curves, n.d.
23 21
Poly. fitting -- plastic standards, 1973
23 22
Posh, 8/6/80
23 23
Pulse experiments parameters -- 5 rate constants (K4*=0.001), 1986
23 24
Pump schedule sheet, n.d.
23 25
Puromycin -- originals negatives [negatives], n.d.
23 26
Psychological vs. Physiological, 1961
23 27
Radiochemical specifications, 1967-1974
23 28
Rat DX-4, 1971
23 29
Rate constant experiments, 1970-1992
23 30
Red-outline drawings, n.d.
23 31
REM4, awake cont. cat, 1976
23 32
REM5, 1976
23 33
Reproduce Iadecola's experiment, 1992
48 28
Research medicine [experiment proposal], 1992
23 34
Reza, Sept. 10, 1979
23 35
Ribosomal protein -- orig. photos and neg. [photographs, negatives], n.d.
23 36
Roche system -- originals and photographs [negatives], n.d.
23 37
Rocky, n.d.
23 38
Rocky, 10-26-78
23 39
Rocky, film no. 1-32, 1979
23 40
Sakurada abstract -- effects of immobilization, 1977
23 41
Salicylates -- illus. and negatives [negatives], n.d.
23 42
Series AB: laplace transform, 2 DG. rats: BARB. ANES, 1975
23 43
Series AUD-111: auditory alterations, 1973
23 44
Series AUD-2: auditory alterations, 1974
23 45
Series AUD-3: auditory alterations, 1974
23 46
Series AUD-4: auditory alterations, 1974
23 47
Series CB: laplace transform, 2DG. rats: 5% CO2, 1975
23 48
Series NH: ammonium acetate -- 10 m. moles/kg i.p., 1972
23 49
Series normal: normal values in rats, 1971
23 50
Series R-ER-1 to R-ER-7 -- trial at square wave rats -- conscious, 1974
23 51
Series WB: laplace transform, 2DG rats: conscious, 1975
23 52
Shaky, 12-20-79 [photograph], 1979
23 53
Short counts on Beckman L.S5801, 1985
23 54
Sierra, 1980-1984
23 55
Sleep -- spinial cord, n.d.
24 1
Sleep (end Kennedy files), 1980
24 2
Sleep 1 (fang), 2-13-80, 1980
24 3
Sleep study, 1981-1990
24 4
Snooz, Jan. 5, 1980, 1980
24 5
Sparky -- myelinated [photographs], 1983
24 6
Spot -- sleeping, 2-12-81, 1981
24 7
Standard calibration, 1979
24 8
Standard strip calibration from G. Dauth, neurosci., Univ. of Mich., Feb. 9, 1980, 1980
24 9
Standards, 1979-1983
24 10
Sugar, 1979
24 11
Sugar, film no. 1-28, 1979
24 12
Summarized data for computer analysis, n.d.
24 13
Summary of parameters (pulse exp.) (square exp.), n.d.
24 14
Summary of parameters (square exp), n.d.
24 15
Summary sheets, 1968-1974
24 16-20
Summary tables and graphs, n.d.
24 21
T3 Be Vwa time course data for Dr. Greenhouse, n.d.
24
TAK - CY20 - CY29 [CD-ROMs], n.d.
24 22
Tent rat training record, 1993
24 23
TSC-1, Nov. 10, 1975
24 24
TSC-2, Dec. 1, 1975
24 25
TSC-3, Dec. 2, 1975
24 26
TSC-4, Dec. 4, 1975
24 27
Values of rate constants in the normal conscious albino rat, n.d.
24 28
Visual alteration: enucleation, 1973
24 29
Weighted average concentration -- (pulse experiments) Dr. Shinohara's data, 1986
24 30
Whole blood samples, n.d.
24 31
Windy, 1978
24 32
Windy [photograph], 1978-1979
24 33
Windy, film no. 7-33, 1978
24 34
Winx, 1985
24 35
Winx (sleep control), 1980
24 36
Winx, film 16, 1987